NCT06180213View on ClinicalTrials.gov

Study of Cerebral Glucose Metabolism in Neurodegenerative Diseases and Head Trauma

CompletedOBSERVATIONAL

Enrollment

1,570

Participants

Timeline

Start Date

October 1, 2015

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions

Neurodegenerative Diseases

Interventions

DIAGNOSTIC_TEST

FDG PET

Distribution pattern of the FDG tracer in patients with neurodegenerative diseases and identify the regions of altered brain function specific for each clinical condition.

All Listed Sponsors

lead

IRCCS San Raffaele

OTHER

NCT06180213 - Study of Cerebral Glucose Metabolism in Neurodegenerative Diseases and Head Trauma | Biotech Hunter | Biotech Hunter